Literature DB >> 15471947

Evidence that an isoform of calpain-10 is a regulator of exocytosis in pancreatic beta-cells.

Catriona Marshall1, Graham A Hitman, Christopher J Partridge, Anne Clark, Hong Ma, Thomas R Shearer, Mark D Turner.   

Abstract

Calpain-10 (CAPN10) is the first type 2 diabetes susceptibility gene to be identified through a genome scan, with polymorphisms being associated with altered CAPN10 expression. Functional data have been hitherto elusive, but we report here a corresponding increase between CAPN10 expression level and regulated insulin secretion. Pancreatic beta-cell secretory granule exocytosis is mediated by the soluble N-ethylmaleimide-sensitive fusion protein attachment receptor protein complex of synaptosomal-associated protein of 25 kDa (SNAP-25), syntaxin 1, and vesicle-associated membrane protein 2. We report, for the first time, direct binding of a calpain-10 isoform with members of this complex. Furthermore, SNAP-25 undergoes a Ca2+-dependent partial proteolysis during exocytosis, with calpain protease inhibitor similarly suppressing both insulin secretion and SNAP-25 proteolysis. Based upon these findings, we postulate that an isoform of calpain-10 is a Ca2+-sensor that functions to trigger exocytosis in pancreatic beta-cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15471947     DOI: 10.1210/me.2004-0064

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  30 in total

1.  Calpain-10 Activity Underlies Angiotensin II-Induced Aldosterone Production in an Adrenal Glomerulosa Cell Model.

Authors:  Mutsa Seremwe; Rick G Schnellmann; Wendy B Bollag
Journal:  Endocrinology       Date:  2015-04-02       Impact factor: 4.736

2.  Association of diabetes susceptibility gene calpain-10 with pancreatic cancer among smokers.

Authors:  Pui-yee Fong; Megan D Fesinmeyer; Emily White; Federico M Farin; Sengkeo Srinouanprachanh; Zahra Afsharinejad; Margaret T Mandelson; Teresa A Brentnall; Matt J Barnett; Gary E Goodman; Melissa A Austin
Journal:  J Gastrointest Cancer       Date:  2010-09

3.  Association of the E23K polymorphism in the KCNJ11 gene with gestational diabetes mellitus.

Authors:  N Shaat; M Ekelund; A Lernmark; S Ivarsson; P Almgren; K Berntorp; L Groop
Journal:  Diabetologia       Date:  2005-11-17       Impact factor: 10.122

4.  Impaired insulin secretion in transgenic mice over-expressing calpastatin in pancreatic β-cells.

Authors:  James D Johnson; Kenichi Otani; Graeme I Bell; Kenneth S Polonsky
Journal:  Islets       Date:  2009 Nov-Dec       Impact factor: 2.694

5.  Calpain 10 homology modeling with CYGAK and increased lipophilicity leads to greater potency and efficacy in cells.

Authors:  Matthew A Smith; Campbell McInnes; Ryan M Whitaker; Christopher C Lindsey; Richard F Comer; Craig C Beeson; Rick G Schnellmann
Journal:  ACS Chem Biol       Date:  2012-05-31       Impact factor: 5.100

Review 6.  Pharmacogenetics of posttransplant diabetes mellitus.

Authors:  P Lancia; T Adam de Beaumais; E Jacqz-Aigrain
Journal:  Pharmacogenomics J       Date:  2017-03-28       Impact factor: 3.550

7.  Identification and optimization of a novel inhibitor of mitochondrial calpain 10.

Authors:  Kyle A Rasbach; David D Arrington; Sina Odejinmi; Chris Giguere; Craig C Beeson; Rick G Schnellmann
Journal:  J Med Chem       Date:  2009-01-08       Impact factor: 7.446

8.  Characterization of endogenous and recombinant human calpain-10.

Authors:  Biao Dong; Rihe Liu
Journal:  Biochimie       Date:  2008-04-10       Impact factor: 4.079

9.  Neuronal calcium sensor synaptotagmin-9 is not involved in the regulation of glucose homeostasis or insulin secretion.

Authors:  Natalia Gustavsson; Xiaorui Wang; Yue Wang; Tingting Seah; Jun Xu; George K Radda; Thomas C Südhof; Weiping Han
Journal:  PLoS One       Date:  2010-11-09       Impact factor: 3.240

10.  Calpain-10 expression is elevated in pancreatic islets from patients with type 2 diabetes.

Authors:  Charlotte Ling; Leif Groop; Silvia Del Guerra; Roberto Lupi
Journal:  PLoS One       Date:  2009-08-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.